Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at SGD 121.5B, ahead of Eli Lilly (SGD 84.1B) and Merck & Co (SGD 83.8B). Figures as of 20 Nov 2026, 10:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonSGD 121.5B
- Median
- SGD 4.1B
- Combined market value
- SGD 6.4T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SGD 121.5B | SGD 829.3B | SGD 344.50 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | SGD 84.1B | SGD 1.55T | SGD 1,742.39 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | SGD 83.8B | SGD 422.2B | SGD 171.27 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | SGD 80.7B | SGD 202.4B | SGD 35.52 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | SGD 78.9B | SGD 646.3B | SGD 365.65 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SGD 75.7B | SGD 350.8B | SGD 226.21 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | SGD 70.3B | SGD 368.3B | SGD 195.01 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | SGD 62.4B | SGD 142.6B | SGD 59.40 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | SGD 62.2B | SGD 153.8B | SGD 75.23 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | SGD 59.1B | SGD 220.9B | SGD 50.13 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | SGD 57.2B | SGD 232B | SGD 133.95 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | SGD 55.9B | SGD 123.6B | SGD 61.67 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | SGD 36.4B | SGD 88.2B | SGD 27.61 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 22.3B | SGD 58B | SGD 49.70 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SGD 18.5B | SGD 123.2B | SGD 1,190.73 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | SGD 18.4B | SGD 29.4B | SGD 25.64 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SGD 15.5B | SGD 170.2B | SGD 671.44 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | SGD 12.2B | SGD 42.3B | SGD 104.19 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | SGD 10.8B | SGD 7.2B | SGD 10.57 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | SGD 6.9B | SGD 58.9B | SGD 515.45 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | SGD 6.1B | SGD 16.9B | SGD 33.90 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 5.5B | SGD 19.6B | SGD 304.92 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | SGD 4.8B | SGD 40.8B | SGD 66.22 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SGD 4.8B | SGD 25.5B | SGD 190.63 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 4.6B | SGD 15.9B | SGD 19.12 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SGD 4.2B | SGD 15.3B | SGD 79.21 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | SGD 4.1B | SGD 30.7B | SGD 721.01 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | SGD 3.9B | SGD 9.6B | SGD 27.58 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | SGD 3.1B | SGD 50.2B | SGD 87.33 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SGD 2.2B | SGD 6.3B | SGD 75.22 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | SGD 1.9B | SGD 10B | SGD 59.55 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4B | SGD 20.76 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.2B | SGD 11.9B | SGD 511.63 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SGD 1.2B | SGD 5.8B | SGD 35.10 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 8B | SGD 56.29 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | SGD 1B | SGD 21.7B | SGD 330.08 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | SGD 981.9M | SGD 9.2B | SGD 83.80 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 873.8M | SGD 9.5B | SGD 120.62 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SGD 823.4M | SGD 9.2B | SGD 174.97 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | SGD 794.8M | SGD 12.6B | SGD 83.67 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | SGD 782M | SGD 40.9B | SGD 186.29 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SGD 672.3M | SGD 8B | SGD 123.17 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | SGD 647.5M | SGD 19.6B | SGD 100.82 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | SGD 632.8M | SGD 6B | SGD 62.29 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | SGD 345.7M | SGD 7.4B | SGD 370.03 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 244.7M | SGD 10.4B | SGD 150.62 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | SGD 113.5M | SGD 9.2B | SGD 66.36 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | SGD 59.3M | SGD 10.4B | SGD 159.93 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | SGD 10.7M | SGD 36.4B | SGD 50.24 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | SGD 2.6M | SGD 6.2B | SGD 109.40 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | SGD 0 | SGD 12B | SGD 125.90 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | SGD 0 | SGD 11.2B | SGD 400.93 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2896 SGD). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (SGD 121.5B), Eli Lilly (SGD 84.1B) and Merck & Co (SGD 83.8B) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 10:50 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of SGD 6.4T as of 20 Nov 2026, 10:50 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.